Percorso:ANSA > Nuova Europa > Germany > Pfizer seeks EU vaccine approval
Pfizer seeks EU vaccine approval
It followed the footsteps of competitor Moderna
01 December, 14:02
(ANSA-AFP) - FRANKFURT AM MAIN, DEC 1 - Pharma companies
Pfizer and BioNTech on Tuesday filed for European approval for
their coronavirus vaccine, following in the footsteps of
competitor Moderna. US giant Pfizer and German newcomer BioNTech
said their vaccine could be rolled out "in Europe before the end
of 2020" if the European Medicines Agency grants so-called
Conditional Marketing Authorisation. Moderna had applied on
Monday for both US and EU approval of its vaccine, based on the
same new mRNA technology and with a similar level of
effectiveness at around 95 percent. (ANSA-AFP).
© Copyright ANSA - All rights reserved
